301370SZSE

Q1 2026 Report

✨ AI Summary

The Q1 2026 report of Guoke Hengtai (Beijing) Medical Technology Co., Ltd. reveals a 9.81% decrease in revenue compared to the same period last year, totaling approximately 1.57 billion yuan. However, net profit attributable to shareholders increased significantly by 113.90%, reaching about 1.24 million yuan. The report indicates a substantial decline in cash flow from operating activities, down 73.38% year-on-year, highlighting challenges in cash generation despite improved profitability.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Important Content Reminder

  1. The Board of Directors and senior management guarantee the truthfulness, accuracy, and completeness of the quarterly report, with no false records, misleading statements, or significant omissions, and assume individual and joint legal responsibilities.
  2. The person in charge of the company, the head of accounting, and the accounting institution declare that the financial information in the quarterly report is true, accurate, and complete.
  3. The quarterly financial report has not been audited.

I. Main Financial Data

(1) Main Accounting Data and Financial Indicators

The company does not need to retrospectively adjust or restate previous years' accounting data.

ItemCurrent PeriodSame Period Last YearChange (%)
Operating Revenue (CNY)1,567,772,898.151,738,389,865.52-9.81%
Net Profit Attributable to Shareholders (CNY)1,244,026.72-8,952,497.24113.90%
Net Profit Attributable to Shareholders Excluding Non-Recurring Gains and Losses (CNY)564,257.84-10,879,505.09105.19%
Net Cash Flow from Operating Activities (CNY)105,893,650.37397,850,648.04-73.38%
Basic Earnings per Share (CNY/share)0.003-0.02115.00%
Diluted Earnings per Share (CNY/share)0.003-0.02115.00%
Weighted Average Return on Equity0.05%-0.36%0.41%
ItemEnd of Current PeriodEnd of Last YearChange (%)
Total Assets (CNY)6,169,028,693.416,340,042,288.33-2.70%
Total Equity Attributable to Shareholders (CNY)2,508,435,328.852,507,191,302.130.05%

(2) Non-Recurring Gains and Losses

ItemAmount (CNY)Description
Loss from Disposal of Non-Current Assets-6,071.38
Government Subsidies Included in Current Profit and Loss203,644.31Excluding those closely related to normal business operations
Reversal of Impairment Provision for Receivables39,607.01
Other Non-Operating Income and Expenses252,682.44
Other Gains and Losses Meeting Non-Recurring Definition206,400.73
Less: Income Tax Impact-177,671.81
Impact on Minority Interests (after tax)-161,177.58
Total679,768.88

(3) Changes and Reasons for Main Accounting Data and Financial Indicators

  1. Profit and Loss Statement Items

    • Net Profit Attributable to Shareholders (CNY): 1,244,026.72 (113.90% increase) mainly due to reduced sales expenses and credit impairment losses.
    • Basic Earnings per Share (CNY/share): 0.003 (115.00% increase) mainly due to reduced sales expenses and credit impairment losses.
    • Diluted Earnings per Share (CNY/share): 0.003 (115.00% increase) mainly due to reduced sales expenses and credit impairment losses.
  2. Cash Flow Statement Items

    • Net Cash Flow from Operating Activities (CNY): 105,893,650.37 (-73.38% decrease) mainly due to reduced cash received from sales.
  3. Other Important Financial Indicators

    • Net Profit Attributable to Shareholders Excluding Non-Recurring Gains and Losses (CNY): 564,257.84 (105.19% increase) mainly due to reduced sales expenses and credit impairment losses.

II. Shareholder Information

(1) Total Number of Common Shareholders and Number of Preferred Shareholders with Restored Voting Rights

ItemValue
Total Number of Common Shareholders at Period End17,114
Total Number of Preferred Shareholders with Restored Voting Rights at Period End0

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.